Latest News & Features
Big Pharma
Pharmaceutical company Bayer has revealed that it is offering to buy Monsanto for $62 billion. 24 May 2016
article
China has said that it will reduce the price of three top-selling patented drugs by more than 50%. 24 May 2016
Americas
Colombia’s health ministry has warned Novartis that it might override a patent that the company owns covering cancer drug Gleevec. 20 May 2016
Americas
Law firm Lathrop & Gage has hired Alan Steele as a counsel in its intellectual property practice group in Boston. 19 May 2016
Europe
Bayer and ERS Genomics have signed a patent licensing agreement which gives Bayer access to ERS’s CRISPR/Cas9 genome-editing patents. 19 May 2016
Americas
Amgen has sued Sandoz for allegedly infringing two patents related to cancer drug Neulasta, following Sandoz’s plans to sell a biosimilar version of the drug. 19 May 2016
Americas
US-based law firm Burns & Levinson has hired Shawn Foley as of counsel in the firm’s intellectual property practice in Boston. 19 May 2016
Africa
It is likely that many patent applications directed to CRISPR technology will be filed in India, says Hemant Singh of Inttl Advocare, who analyses some of the early applications and the rules on patentability. 19 May 2016
Americas
Pfizer has announced that it will be buying Anacor Pharmaceuticals for $5.2 billion, which will lead to it adding an experimental treatment for eczema, called Crisaborole, to its portfolio. 18 May 2016
Americas
The US Patent and Trademark Office’s Patent Trial and Appeal Board will review one of AbbVie’s patents covering its arthritis treatment drug Humira (adalimumab), following a challenge by drug maker Coherus Bioscience. 18 May 2016